<p>N-ethylpentedrone (NEP) is a New Psychoactive Substance (NPS) of the cathinone class that has raised public health concerns, scheduled by both the United Nations Office on Drugs and Crime and the European Union Drugs Agency, since 2024. We report here a fatal case involving a 29-years-old man who used NEP in a chemsex context. Three plastic bags containing off-white to beige powders and crystals were found near the body. Proton and carbon nuclear magnetic resonance spectrometry (<sup>1</sup>H and <sup>13</sup>C NMR) and ultra-high performance liquid chromatography-high-resolution mass spectrometry (UHPLC-HRMS) analyses confirmed all three bags contained NEP with purity above 98%. UHPLC-HRMS data analyses using molecular networking and in silico prediction allowed to propose NEP metabolic profile in peripheral and cardiac blood, bile, gastric fluid, urine and hair. We described here six Phase I metabolites, and we proposed NEP (C<sub>13</sub>H<sub>19</sub>NO) as the principal biomarker in NEP intake, metabolites M4 (C<sub>11</sub>H<sub>17</sub>NO) and M1 (C<sub>11</sub>H<sub>15</sub>NO) serving as biomarkers of consumption, as all of which were detected in all postmortem body fluid samples as well as in hair. Predominant metabolic pathways involved keto-reduction, N-dealkylation, hydroxylation, and oxidation, while no Phase II metabolites were detected under the applied analytical conditions. NEP was quantified at 18&#xa0;mg/L and 20&#xa0;mg/L in peripheral and cardiac blood, respectively, and 654–755 pg/mg in hair. These exceptionally high concentrations in biological fluids indicate an acute NEP intoxication, while hair analyses confirm repeated exposure over several months, consistent with chronic use. In summary, the identification of these metabolites in various postmortem body fluid matrices and in hair will improve our understanding of potential drug consumption markers and contribute to better monitoring and detection of N-ethylpentedrone use and abuse.</p>

错误:搜索内容不能为空,请输入英文关键词
错误:关键词超出字数限制,请精简
高级检索

N-Ethylpentedrone: first hair detection and human metabolic profiling across multiple biological matrices using UHPLC-HRMS, molecular networking and in silico prediction

  • Agathe Pasquet,
  • Romain Pelletier,
  • Roxane Rouah,
  • Tania Panter,
  • Mélanie Loiseau,
  • François-Hugues Porée,
  • Thomas Gicquel,
  • Pascal Guerard

摘要

N-ethylpentedrone (NEP) is a New Psychoactive Substance (NPS) of the cathinone class that has raised public health concerns, scheduled by both the United Nations Office on Drugs and Crime and the European Union Drugs Agency, since 2024. We report here a fatal case involving a 29-years-old man who used NEP in a chemsex context. Three plastic bags containing off-white to beige powders and crystals were found near the body. Proton and carbon nuclear magnetic resonance spectrometry (1H and 13C NMR) and ultra-high performance liquid chromatography-high-resolution mass spectrometry (UHPLC-HRMS) analyses confirmed all three bags contained NEP with purity above 98%. UHPLC-HRMS data analyses using molecular networking and in silico prediction allowed to propose NEP metabolic profile in peripheral and cardiac blood, bile, gastric fluid, urine and hair. We described here six Phase I metabolites, and we proposed NEP (C13H19NO) as the principal biomarker in NEP intake, metabolites M4 (C11H17NO) and M1 (C11H15NO) serving as biomarkers of consumption, as all of which were detected in all postmortem body fluid samples as well as in hair. Predominant metabolic pathways involved keto-reduction, N-dealkylation, hydroxylation, and oxidation, while no Phase II metabolites were detected under the applied analytical conditions. NEP was quantified at 18 mg/L and 20 mg/L in peripheral and cardiac blood, respectively, and 654–755 pg/mg in hair. These exceptionally high concentrations in biological fluids indicate an acute NEP intoxication, while hair analyses confirm repeated exposure over several months, consistent with chronic use. In summary, the identification of these metabolites in various postmortem body fluid matrices and in hair will improve our understanding of potential drug consumption markers and contribute to better monitoring and detection of N-ethylpentedrone use and abuse.